Banne Ehud, Meiner Vardiella, Shaag Avraham, Katz-Brull Rachel, Gamliel Ayelet, Korman Stanley, Cederboim Smadar Horowitz, Duvdevani Morasha Plesser, Frumkin Ayala, Zilkha Amir, Kapuller Vadim, Arbell Dan, Cohen Elite, Eventov-Friedman Smadar
Department of Genetics and Metabolic Diseases, Hadassah, Hebrew University Medical Center, Jerusalem, Israel.
Monique and Jacques Roboh Department of Genetic Research, Hebrew University Medical Center, Jerusalem, Israel.
JIMD Rep. 2016;26:31-6. doi: 10.1007/8904_2015_474. Epub 2015 Aug 4.
Transaldolase (TALDO) deficiency has various clinical manifestations including liver dysfunction, hepatosplenomegaly, anemia, thrombocytopenia, and dysmorphic features. We report a case presenting prenatally with hyperechogenic bowel and intrauterine growth restriction. The infant was born small for gestational age, with cutis laxa and hypertrichosis. Postnatally, meconium plug was identified, complicated with intestinal obstruction necessitating laparotomy, partial resection of the intestine, and ileostomy. Liver biopsy revealed cholangiolar proliferation and portal fibrosis. He also suffered from persistent congenital thrombocytopenia requiring platelet transfusions and severe hypothyroidism with normal anatomical and structural gland responding only to the combination of T3 and T4 treatment. Neurologically, severe hypotonia and anisocoria were noted at the age of 2 months. Brain MRI was normal. Shortly after the abdominal surgery, a rapid liver failure ensued, which eventually led to his death. Specific metabolic tests ruled out glycosylation disorders, yet urine analysis using 1H NMR showed accumulation of sedoheptulose which was previously described in patients with transaldolase deficiency. Sequencing of the gene-encoding transaldolase (TALDO1) revealed a homozygous stop mutation c.669C>G; p.Tyr223*. In conclusion, we present an infant with a novel homozygous mutation in TALDO1, causing TALDO deficiency, and extend the clinical characteristics of this rare syndrome.
转醛醇酶(TALDO)缺乏症有多种临床表现,包括肝功能障碍、肝脾肿大、贫血、血小板减少和畸形特征。我们报告一例产前表现为肠回声增强和宫内生长受限的病例。该婴儿出生时小于胎龄,有皮肤松弛和多毛症。出生后,发现胎粪堵塞,并伴有肠梗阻,需要进行剖腹手术、部分肠切除和回肠造口术。肝活检显示胆小管增生和门脉纤维化。他还患有持续性先天性血小板减少症,需要输注血小板,以及严重甲状腺功能减退症,甲状腺解剖结构正常,仅对T3和T4联合治疗有反应。神经方面,2个月大时发现严重肌张力减退和瞳孔不等大。脑部MRI正常。腹部手术后不久,迅速出现肝衰竭,最终导致死亡。特定的代谢检查排除了糖基化障碍,但使用1H NMR进行的尿液分析显示景天庚酮糖积累,这在之前的转醛醇酶缺乏症患者中已有描述。编码转醛醇酶(TALDO1)的基因测序显示纯合终止突变c.669C>G;p.Tyr223*。总之,我们报告了一名婴儿,其TALDO1基因存在新的纯合突变,导致TALDO缺乏,并扩展了这种罕见综合征的临床特征。